N-acetylcysteine for treatment of anemia in children with kidney failure: a prospective study

Abstract Background and purpose Chronic kidney disease (CKD) results from irreversible kidney damage and is primarily linked to glomerular diseases and congenital anomalies in children. Patients with CKD experience increased oxidative stress. N-acetyl cysteine (NAC) is a synthetic form of cysteine that breaks down into glutathione, which acts as an antioxidant. This study aimed to evaluate the effects of NAC on hematological and cardiac indices in children with kidney failure undergoing hemodialysis. Methods This prospective study included 48 children with kidney failure who were on maintenance hemodialysis. Six patients were subsequently excluded because of drug intolerance. The study gathered data on the original cause of CKD, initiation of hemodialysis, weight, height, and BMI. Initial and follow-up assessments included blood count, calcium profile, iron profile, markers of oxidative stress, and 2-D echocardiography to evaluate cardiac contractility and LV diameters. All participants were given oral NAC daily for 3 months. Results The average age of the patients was 10.2 ± 3.35 years, and the average duration of dialysis was 3.9 ± 2.87 years. Our research revealed that NAC has strong antioxidant properties. This was shown by a significant increase in total antioxidant capacity (TAC) and a notable decrease in total oxidative stress (TOS) after 3 months of NAC administration. NAC was also found to improve anemia in the participants, as demonstrated by a significant increase in hemoglobin levels after treatment compared with the baseline measurements in the current study. Additionally, a significant reduction in ferritin levels was observed after 3 months of administration of NAC. Furthermore, we discovered that NAC has a protective effect against cardiovascular disorders associated with CKD, as evidenced by the significant improvement in the LV diameter and cardiac contractility. Conclusion NAC can improve anemia and cardiac function, and reduce oxidative stress in children with kidney failure undergoing maintenance hemodialysis.

Authors

Institutions

Publication Details

Journal
Renal Replacement Therapy
Published
2025-09-28
DOI
https://doi.org/10.1186/s41100-025-00671-2
Primary Topic
Pharmacological Effects and Toxicity Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

N-acetylcysteine for treatment of anemia in children with kidney failure: a prospective study

Heba Mostafa Ahmed, Fatma Abdel Maksoud, Raghda R. S. Hussein, Yasmin Ramadan et al.
Renal Replacement Therapy
Pharmacological Effects and Toxicity Studies
article

N-acetylcysteine for treatment of anemia in children with kidney failure: a prospective study

Heba Mostafa Ahmed, Fatma Abdel Maksoud, Raghda R. S. Hussein, Yasmin Ramadan, Ahmed R. Sayed, Ahmed S. Abdelwahed
article en

Abstract

Abstract Background and purpose Chronic kidney disease (CKD) results from irreversible kidney damage and is primarily linked to glomerular diseases and congenital anomalies in children. Patients with CKD experience increased oxidative stress. N-acetyl cysteine (NAC) is a synthetic form of cysteine that breaks down into glutathione, which acts as an antioxidant. This study aimed to evaluate the effects of NAC on hematological and cardiac indices in children with kidney failure undergoing hemodialysis. Methods This prospective study included 48 children with kidney failure who were on maintenance hemodialysis. Six patients were subsequently excluded because of drug intolerance. The study gathered data on the original cause of CKD, initiation of hemodialysis, weight, height, and BMI. Initial and follow-up assessments included blood count, calcium profile, iron profile, markers of oxidative stress, and 2-D echocardiography to evaluate cardiac contractility and LV diameters. All participants were given oral NAC daily for 3 months. Results The average age of the patients was 10.2 ± 3.35 years, and the average duration of dialysis was 3.9 ± 2.87 years. Our research revealed that NAC has strong antioxidant properties. This was shown by a significant increase in total antioxidant capacity (TAC) and a notable decrease in total oxidative stress (TOS) after 3 months of NAC administration. NAC was also found to improve anemia in the participants, as demonstrated by a significant increase in hemoglobin levels after treatment compared with the baseline measurements in the current study. Additionally, a significant reduction in ferritin levels was observed after 3 months of administration of NAC. Furthermore, we discovered that NAC has a protective effect against cardiovascular disorders associated with CKD, as evidenced by the significant improvement in the LV diameter and cardiac contractility. Conclusion NAC can improve anemia and cardiac function, and reduce oxidative stress in children with kidney failure undergoing maintenance hemodialysis.

Renal Replacement TherapyVol. 11(1)
Beni-Suef University (EG), Cairo University (EG)
Openalex Percentile: Top 63%
Pharmacological Effects and Toxicity Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.